KYSEF(KYSEF)
KYSEF
No analyst ratings available
No analyst price targets available for KYSEF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $2.31T | $2.32T | $2.32T | $2.31T | $2.32T |
| Low | $2.27T | $2.28T | $2.28T | $2.28T | $2.29T |
| High | $2.35T | $2.34T | $2.35T | $2.35T | $2.36T |
| EBITDA Avg | $734.98B | $739.79B | $739.47B | $737.08B | $740.95B |
| Low | $724.20B | $727.45B | $727.88B | $725.53B | $729.34B |
| High | $748.78B | $747.16B | $750.09B | $747.66B | $751.59B |
| EBIT Avg | $503.32B | $506.61B | $506.39B | $504.76B | $507.40B |
| Low | $495.94B | $498.16B | $498.45B | $496.84B | $499.45B |
| High | $512.76B | $511.65B | $513.66B | $512.00B | $514.69B |
| Net Income Avg | $128.84B | $133.77B | $133.90B | $139.92B | $138.59B |
| Low | $126.22B | $131.05B | $131.17B | $137.07B | $135.76B |
| High | $131.25B | $136.27B | $136.40B | $142.53B | $141.17B |
| EPS Avg | $272.56 | $283.00 | $283.27 | $295.99 | $293.18 |
| Low | $267.01 | $277.23 | $277.50 | $289.96 | $287.21 |
| High | $277.65 | $288.28 | $288.55 | $301.52 | $298.65 |
| Analysts (Rev / EPS) | 5 / 1 | 5 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $610.59B | $551.22B | $620.92B |
| Low | $590.79B | $533.35B | $600.79B |
| High | $630.38B | $569.09B | $641.04B |
| EBITDA Avg | $194.64B | $175.72B | $197.94B |
| Low | $188.33B | $170.02B | $191.52B |
| High | $200.95B | $181.42B | $204.35B |
| EBIT Avg | $133.29B | $120.33B | $135.55B |
| Low | $128.97B | $116.43B | $131.15B |
| High | $137.61B | $124.23B | $139.94B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 2 / — | 1 / — | 1 / — |